Objectives: The purpose of this study was to prospectively evaluate the feasibility and diagnostic value of right ventricular overdrive pacing (RVOP) during supraventricular tachycardia (SVT) using a 2-catheter approach with automatic pacing from the right ventricular inflow (RVIT) and outflow tract (RVOT). Methods: One hundred and thirty-six consecutive patients (with 138 arrhythmias, mean age 36 ± 20 years, range 4-95) were enrolled in this study. Only coronary sinus and ablation catheters were used. RVOP was delivered from RVIT and then from RVOT. Each attempt consisted of 10 synchronized beats delivered at a cycle length of 10-40 ms longer than the tachycardia cycle length. Results: RVOP was sufficient to confirm the transition zone within the first 9 beats in the majority of SVTs. Atrial perturbation (acceleration, delayed) in the transition zone was detected in all patients with orthodromic atrioventricular (AV) reentry. Patients with typical AV nodal reentry, atypical AV nodal reentry and atrial tachycardia did not show atrial timing perturbation during fusion complexes of RVOP. Conclusions: Synchronized RVOP from RVIT or RVOT is an easy and accurate method for the quick and reliable differential diagnosis of SVT in various clinical settings, particularly when only a limited number of catheters are used.

Keywords:
Supraventricular tachycardia, Entrainment, Atrioventricular nodal reentrant tachycardia, Atrial tachycardia, Orthodromic atrioventricular reentry
1.
Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias). Circulation 2003;108:1871-1909.
2.
García-Bolao I, Díaz-Infante E, Gallego AM: Spanish catheter ablation registry. Seventh official report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2007). Rev Esp Cardiol 2008;61:1287-1297.
3.
Liew R, Mullan V, Richmond L, Rajappan K, Gupta D, Thomas G, Redpath C, Earley M, Harris S, Sporton S, Schilling R: Comparison of conventional with minimal catheter approaches for mapping and ablation of cardiac arrhythmias: a randomized controlled trial. Europace Suppl 2007;9(suppl 5).
4.
Brugada J, Matas M, Mont L, Petit M, Navarro-Lopez F: One thousand consecutive radiofrequency ablation procedures. Indications, results, and complications. Rev Esp Cardiol 1996;49:810-814.
5.
Femenía F, Arce M, Arrieta M, Palazzolo J, Trucco E: Long-term results of slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia: simple approach. J Electrocardiol 2012;45:203-208.
6.
Drago F, Russo MS, Marazzi R, Salerno- Uriarte JA, Silvetti MS, De Ponti R: Atrial tachycardias in patients with congenital heart disease: a minimally invasive simplified approach in the use of three-dimensional electroanatomic mapping. Europace 2011;13:689-695.
7.
Mont L, Brugada J: Electrophysiology: it is time to simplify! Europace 2009;11:985-986.
8.
Shoei K, Huang S, Wood M: Catheter Ablation of Cardiac Arrhythmias, ed 2. Philadelphia, Saunders, 2010.
9.
Hirao K, Otomo K, Wang X, et al: Para-Hisian pacing: a new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 1996;94:1027-1035.
10.
Martinez-Alday JD, Almendral J, Arenal A, et al: Identification of concealed posteroseptal Kent pathways by comparison of ventriculoatrial intervals from apical and posterobasal right ventricular sites. Circulation 1994;89:1060-1067.
11.
Segal OR, Gula LJ, Skanes AC, Krahn AD, Yee R, Klein GJ: Differential ventricular entrainment: a maneuver to differentiate AV node reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm 2009;6:493-500.
12.
Reddy VY, Jongnarangsin K, Albert CM, et al: Para-Hisian entrainment: a novel pacing maneuver to differentiate orthodromic atrioventricular reentrant tachycardia from atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 2003;14:1321-1328.
13.
Miles WM, Yee R, Klein GJ, Zipes DP, Prystowsky EN: The preexcitation index: an aid in determining the mechanism of supraventricular tachycardia and localizing accessory pathways. Circulation 1986;74:493-500.
14.
González-Torrecilla E, Arenal A, Atienza F, Osca J, García-Fernández J, Puchol A, Sánchez A, Almendral J: First postpacing interval after tachycardia entrainment with correction for atrioventricular node delay: a simple maneuver for differential diagnosis of atrioventricular nodal reentrant tachycardias versus orthodromic reciprocating tachycardias. Heart Rhythm 2006;3:674-679.
15.
Michaud GF, Tada H, Chough S, Baker R, Wasmer K, Sticherling C, Oral H, Pelosi F Jr, Knight BP, Strickberger SA, Morady F: Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol 2001;38:1163-1167.
16.
Kannankeril PJ, Bonney WJ, Dzurik MV, Fish FA: Entrainment to distinguish orthodromic reciprocating tachycardia from atrioventricular nodal reentry tachycardia in children. Pacing Clin Electrophysiol 2010;33:469-474.
17.
Dandamudi G, Mokabberi R, Assal C, Das MK, Oren J, Storm R, Vijayaraman P, Miller JM: A novel approach to differentiating orthodromic reciprocating tachycardia from atrioventricular nodal reentrant tachycardia. Heart Rhythm 2010;7:1326-1329.
18.
Almahameed ST, Buxton AE, Michaud GF: New criteria during right ventricular pacing to determine the mechanism of supraventricular tachycardia. Circ Arrhythm Electrophysiol 2010;3:578-584.
19.
Rosman JZ, John RM, Stevenson WG, Epstein LM, Tedrow UB, Koplan BA, Albert CM, Michaud GF: Resetting criteria during ventricular overdrive pacing successfully differentiate orthodromic reentrant tachycardia from atrioventricular nodal reentrant tachycardia despite interobserver disagreement concerning QRS fusion. Heart Rhythm 2011;8:2-7.
20.
Khan AH, Khadem A, Basta MN, Gardner MJ, Parkash R, Gula LJ, Sapp JL: Differential entrainment distinguishes atrioventricular nodal reentry tachycardia from atrioventricular reentrant tachycardia. Pacing Clin Electrophysiol 2010;33:1335-1341.
21.
Mroczek E, Ludwik B, Mazij M, Labus M, Stec S, Sledź J, Spikowski J, Lewczuk J: Non-invasive electrophysiologic study and radiofrequency current ablation of tachycardia responsible for numerous inappropriate ICD interventions in patient with post-infarction dilated cardiomyopathy (in Polish). Kardiol Pol 2010;68:599-603.
22.
Klein LW, Miller DL, Balter S, Laskey W, Haines D, Norbash A, Mauro MA, Goldstein JA: Occupational health hazards in the interventional laboratory: time for a safer environment. Radiology 2009;250:538-544.
23.
Stec S, Sledz J, Mazij M, Ras M, Ludwik B, Labus M, Chrabaszcz M, Banasik M, Bzymek M, Klank-Szafran M, Deutsch K, Sledz A, Szydlowski L: Feasibility of implementation of no-X-ray, no-lead apron, 2-catheter' simplified approach for ablation of supraventricular arrhythmias in children and adults (abstract 8602). Heart Rhythm 2013;10(suppl).
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.